Literature DB >> 24436513

Intra-arterial therapies for metastatic colorectal cancer.

David S Wang1, John D Louie1, Daniel Y Sze1.   

Abstract

Intra-arterial therapies for unresectable hepatic metastases from colorectal cancer include radioembolization (RE) with yttrium-90 microspheres, transarterial chemoembolization (TACE), hepatic arterial infusion, and percutaneous hepatic perfusion using an organ isolation system. In this article, we discuss our approach toward treatment selection, followed by details of how RE and TACE are performed at our institution.

Entities:  

Keywords:  colorectal cancer; drug-eluting beads; irinotecan; liver metastases; radioembolization

Year:  2013        PMID： 24436513      PMCID： PMC3700785          DOI： 10.1055/s-0033-1333649

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN： 0739-9529            Impact factor:   1.513


  55 in total

1.  Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients.

Authors:  Lourens Bester; Baerbel Meteling; Nicholas Pocock; Nick Pavlakis; Terence C Chua; Akshat Saxena; David L Morris
Journal:  J Vasc Interv Radiol       Date:  2011-11-12       Impact factor: 3.464

2.  Consolidation of hepatic arterial inflow by embolization of variant hepatic arteries in preparation for yttrium-90 radioembolization.

Authors:  Mohamed H K Abdelmaksoud; John D Louie; Nishita Kothary; Gloria L Hwang; William T Kuo; Lawrence V Hofmann; David M Hovsepian; Daniel Y Sze
Journal:  J Vasc Interv Radiol       Date:  2011-10       Impact factor: 3.464

3.  Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.

Authors:  Camillo Aliberti; Giammaria Fiorentini; Pier Carlo Muzzio; Fabio Pomerri; Massimo Tilli; Sergio Dallara; Giorgio Benea
Journal:  Anticancer Res       Date:  2011-12       Impact factor: 2.480

4.  Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results.

Authors:  C Aliberti; M Tilli; G Benea; G Fiorentini
Journal:  Anticancer Res       Date:  2006 Sep-Oct       Impact factor: 2.480

Review 5.  State of the art: radiolabeled microspheres treatment for liver malignancies.

Authors:  Amélie Deleporte; Patrick Flamen; Alain Hendlisz
Journal:  Expert Opin Pharmacother       Date:  2010-03       Impact factor: 3.889

6.  Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion.

Authors:  B Y Ha; A Ahmed; D Y Sze; M K Razavi; N Simpson; E B Keeffe; M H Nguyen
Journal:  Aliment Pharmacol Ther       Date:  2007-09-15       Impact factor: 8.171

7.  Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis.

Authors:  M A D Vente; M Wondergem; I van der Tweel; M A A J van den Bosch; B A Zonnenberg; M G E H Lam; A D van Het Schip; J F W Nijsen
Journal:  Eur Radiol       Date:  2008-11-07       Impact factor: 5.315

Review 8.  Liver metastases from colorectal cancer: radioembolization with systemic therapy.

Authors:  Nils H Nicolay; David P Berry; Ricky A Sharma
Journal:  Nat Rev Clin Oncol       Date:  2009-11-03       Impact factor: 66.675

9.  Percutaneous hepatic perfusion in patients with metastatic liver cancer: anesthetic, hemodynamic, and metabolic considerations.

Authors:  Ning Miao; James F Pingpank; H Richard Alexander; Seth M Steinberg; Tatiana Beresneva; Zenaide M N Quezado
Journal:  Ann Surg Oncol       Date:  2008-01-08       Impact factor: 5.344

10.  A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy.

Authors:  L Lim; P Gibbs; D Yip; J D Shapiro; R Dowling; D Smith; A Little; W Bailey; M Liechtenstein
Journal:  BMC Cancer       Date:  2005-10-15       Impact factor: 4.430
View more
  8 in total

1.  Current strategies in interventional oncology of colorectal liver metastases.

Authors:  Tatjana Gruber-Rouh; Christian Marko; Axel Thalhammer; Nour-Eldin Nour-Eldin; Marcel Langenbach; Martin Beeres; Nagy N Naguib; Stephan Zangos; Thomas J Vogl
Journal:  Br J Radiol       Date:  2016-05-26       Impact factor: 3.039

Review 2.  Non-operative therapies for colorectal liver metastases.

Authors:  John L Nosher; Inaya Ahmed; Akshar N Patel; Vyacheslav Gendel; Philip G Murillo; Rebecca Moss; Salma K Jabbour
Journal:  J Gastrointest Oncol       Date:  2015-04

Review 3.  Liver-directed therapies in metastatic colorectal cancer.

Authors:  Margaret E Clark; Richard R Smith
Journal:  J Gastrointest Oncol       Date:  2014-10

Review 4.  Intraarterial Liver-Directed Therapies: The Role of Interventional Oncology.

Authors:  Jenson Ma; Juan Martin Gimenez; Tyler Sandow; Daniel Devun; David Kirsch; Paul Gulotta; Patrick Gilbert; Dennis Kay
Journal:  Ochsner J       Date:  2017

5.  CT Perfusion Imaging Can Predict Patients' Survival and Early Response to Transarterial Chemo-Lipiodol Infusion for Liver Metastases from Colorectal Cancers.

Authors:  Wei-Fu Lv; Jian-Kui Han; De-Lei Cheng; Chun-Ze Zhou; Ming Ni; Dong Lu
Journal:  Korean J Radiol       Date:  2015-07-01       Impact factor: 3.500

Review 6.  The role of interventional oncology in the treatment of colorectal cancer liver metastases.

Authors:  Maria Tsitskari; Dimitris Filippiadis; Chrysostomos Kostantos; Kostantinos Palialexis; Periklis Zavridis; Nikolaos Kelekis; Elias Brountzos
Journal:  Ann Gastroenterol       Date:  2018-12-14

7.  Intra-arterial EmboCept S® and DC Bead® effectively inhibit tumor growth of colorectal rat liver metastases.

Authors:  Christian Ziemann; Jonas Roller; Markus M Malter; Kira Keller; Otto Kollmar; Matthias Glanemann; Michael D Menger; Jens Sperling
Journal:  BMC Cancer       Date:  2019-10-10       Impact factor: 4.430

8.  Same day yttrium-90 radioembolization with single photon emission computed tomography/computed tomography: An opportunity to improve care during the COVID-19 pandemic and beyond.

Authors:  Mohammad Elsayed; Mohammad Loya; James Galt; David M Schuster; Zachary L Bercu; Janice Newsome; David Brandon; Sonia Benenati; Keywan Behbahani; Richard Duszak; Ila Sethi; Nima Kokabi
Journal:  World J Gastrointest Oncol       Date:  2021-05-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.